Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Precision Medicine"


25 mentions found


download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . You can opt-out at any time by visiting our Preferences page or by clicking "unsubscribe" at the bottom of the email. Barnes-Lentz is the "Chief Health Officer" in her relationship, and has introduced her husband to treatments such as red light therapy. I asked him for health test results really early on because we were excited to be able to optimize our health together. He was ambitious, we shared faith, he had an interest in health, and we wanted the same things for our futures.
Persons: Kayla Barnes, Lentz, Barnes, , Masha Maltsava, Warren, I've, Warren Lentz Organizations: Service, Raya Locations: LA, Cleveland
Nine health-care stocks have more than doubled in price this year, but still have more than 100% upside potential, according to analysts. All have a "buy" or equivalent rating, and every single one expects the stock to more than double over the next 12 months. The median average price target of $66.50 from eight analysts points to a 252% upside potential over the next 12 months. Benitec is expected to rise by 104% over the next 12 months, according to the median price target of five analysts. Humacyte has doubled this year, and analysts expect it to double again over the next 12 months.
Persons: Benitec, Arcutis, Stocks, Rezolute Rezolute, Trevi, Arcutis Biotherapeutics, Humacyte Organizations: CNBC Pro, Nasdaq, Jasper Therapeutics, Corbus Pharmaceuticals, Rezolute, Trevi Therapeutics, Delcath Systems, Precision Medicines, Jasper Therapeutics Jasper Therapeutics, Pharmaceuticals Corbus Pharmaceuticals, Trevi Therapeutics Trevi Therapeutics, Systems Delcath Systems, Praxis, Medicines Locations: Jasper, Jasper Therapeutics Jasper, Massachusetts, California, U.S, Europe, Australia, Hayward , California
Diabetes startup Omada Health has confidentially filed its S-1 for an IPO, BI has learned. Fellow healthcare startup Hinge Health has hired banks as it prepares to confidentially file its S-1. AdvertisementRumors about diabetes startup Omada Health's public market debut have been swirling for years. Omada Health confidentially filed its S-1 this summer to go public, according to one person with knowledge of the transaction. After 20 healthcare startups went public in 2021, only one healthcare company went public the following year — Akili Interactive, which sold for $34 million this July.
Persons: , Health confidentially, It's, Sean Duffy, Morgan Stanley, Cameron Lester, Ben Narasin, Duffy, Omada Organizations: BI, Service, Health, Lyra, Tempus, Jefferies, Venture, Amazon
Read previewA doctor who claims to have reversed his age by 20 years shared the foods he eats weekly in a bid to boost his longevity. Related storiesOlive oilRoizen said he has a tablespoon of olive oil every day. Plus, replacing margarine, butter, mayonnaise, and dairy fats with olive oil appeared to lower the risk of dying by up to 34%. AdvertisementThe authors suggested that this could be because of the anti-inflammatory and antioxidant properties of olive oil, or because people who consumed more olive oil also tended to be more active, less likely to smoke, and ate more fruits and vegetables. CauliflowerRoizen makes a "cauliflower creamer" by blending the vegetable with olive oil and using it as a spread.
Persons: , Michael Roizen, Roizen, Florence Comite, Caterina Oltean Organizations: Service, Cleveland Clinic, Business, American College of Cardiology, European, of Nutrition, China's Zhejiang University School of Medicine, National Cancer Institute, Penn State University, Lund University, American Heart Association, Centers for Disease Control Locations: Florence, Sweden
Wall Street analysts are bullish on recently launched health-care technology stock Tempus AI . By combining a patient's molecular, clinical, and imaging data with its AI platform, Tempus delivers personalized therapy decisions," he wrote. Tempus AI debuted at the Nasdaq on June 14, closing at $40 after pricing its initial public offering at $37. Last month, investment management firm SoftBank announced it had invested about $200 million in Tempus AI before its Nasdaq listing. Since its debut, Tempus AI stock has slipped 10% from its IPO price.
Persons: Michael Ryskin, SoftBank, America's Ryskin, Ryskin, JPMorgan's Rachel Vatnsdal, William Blair, Morgan Stanley, Tejas Savant, TD Cowen, Dan Brennan Organizations: Bank of America, Tempus, Nasdaq, America's, Precision Oncology, Loop Capital Locations: Stifel, Needham
TD Cowen raised its price target on Netflix, calling for 13% upside for the stock. JPMorgan analyst Rachel Vatnsdal was similarly bullish with her $42 price target, while Morgan Stanley analyst Tejas Savant set a price target of $44. The analyst also raised his price target to $42 from $37, indicating a potential 3% upside from the stock's Monday afternoon close. — Lisa Kailai Han 5:44 a.m.: TD Cowen lifts Netflix price target ahead of second-quarter earnings announcement TD Cowen expects more gains ahead for Netflix . NFLX YTD mountain NFLX year to date — Lisa Kailai Han 5:44 a.m.: KeyBanc hikes Nvidia price target The good times for Nvidia are not over yet, according to KeyBanc.
Persons: TD Cowen, KeyBanc, Morgan Stanley, Bank of America Michael Ryskin, Ryskin, Rachel Vatnsdal, Tejas Savant, Morgan Stanley's Savant, William Blair, Stifel, Lisa Kailai Han, Wells, Donald Fandetti, Fandetti, — Lisa Kailai Han, Grayson, Daniel Lungo, Piper Sandler, Scott Siefers, BAC's NII, Siefers, JPMorgan Chase, Cowen, John Blackledge, Blackledge, John Vinh, Fred Imbert Organizations: CNBC, Netflix, Nvidia, Wall, Tempus, Nasdaq, JPMorgan, Bank of America, Precision Oncology, Needham, American Express, Devon Energy, of America, Citigroup, Blackwell, Wolfe Research, UBS Locations: Devon, Williston, Netflix's, Monday's, 2H24, GB200
Skydance and its financial backers will invest more than $8 billion into Paramount and to acquire National Amusements, Paramount's controlling shareholder. Morphic Holding – Shares rallied 75% on news that Eli Lilly will acquire the biopharmaceutical company in a $3.2 billion deal . The deal will give Eli Lilly access to Morphic's portfolio of treatments in development, such as those for ulcerative colitis and Crohn's disease. Shares of Eli Lilly advanced 1.3% on the news. Boeing – Shares fell slightly after the airplane maker agreed to plead guilty to criminal fraud related to the fatal 737 Max crashes, sparing Boeing from a trial.
Persons: Eli Lilly, BofA, Corning, Guggenheim, Max, Grayson, Raymond James, Samantha Subin, Pia Singh, Hakyung Kim, Sarah Min, Michelle Fox Organizations: Paramount Global, Skydance Media, Skydance, Paramount, National, Morphic, Ideaya Biosciences, Bank of America, Boeing –, Boeing, ., CNBC, Devon Energy, Gilead Sciences Locations: Columbia, Stifel, Williston, Gilead
Tempus AI = AI in healthcare Tempus AI is seeking to sell 11 million shares at $35-$37 in its IPO and is slated to begin trading this Friday. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. AI IPOs: few and far between While AI is again the big investment theme of 2024, AI-themed IPOs have been few and far between. But the appetite for AI IPOs is large, and investors are scanning for new investments. Although the anticipated flood of AI IPOs has not yet materialized, Matt Kennedy is confident more are coming.
Persons: Matt Kennedy, Howe Ng, Ng, IPOs Organizations: Nasdaq, Astera Labs, Renaissance Capital, Nvidia, Cerebras Systems, Citigroup, Tempus, Forge Global Holdings
"I do a little bit of low intensity. AdvertisementThe first is "very low intensity, very long duration." "Anything where it's a very low heart rate for at least 30 minutes or longer continuously." The second is somewhere in between low intensity and full throttle. "It's not max effort, but it's not low intensity," he said.
Persons: , Andy Galpin, Galpin, Jon Rahm, Travis Barker, they're, Bryan Johnson, Andrew Huberman's Huberman, He's, it's Organizations: Service, Business, Clippers, California State University, Fullerton, Research, sarcopenia, National Institute, Aging
They can track a patient's health over time, suggesting personalized interventions. AdvertisementDonaldson was one of the first customers at Twin Health. Twin Health is the only company that leverages digital twin AI for diabetes "reversal" — or, as doctors prefer to say, "remission." If his blood sugar starts going up, he's noticed that getting out for a walk can help bring it back down. "All of my information goes in and it talks to me like a smarter version of myself saying, 'you ate this, this was really good.
Persons: , Devlin Donaldson, he'd, that's, Donaldson, I'm, Omada, Twin's, Twin, he's, Nicola Guess, Guess, she's Organizations: Service, Business, Twin Health, Virta, Oxford University, Apple Watch, Twin Health Healthcare, McKinsey & Company
Dr. Florence Comite is a precision medicine doctor who specializes in healthy aging. She shared five diet tips she shares with patients to help them live longer. AdvertisementA precision medicine doctor shared with Business Insider six diet tips she gives her patients to help them live healthily for as long as possible. A separate study from 2023 found that people who ate diets rich in whole grains, nuts, and fruit lived around 10 years longer than those who consumed more red meat, processed foods, and sugary drinks. 10'000 Hours/ GettyDespite its name, the Mediterranean diet is more of an eating plan that is low in processed foods and red meat.
Persons: , Florence Comite, jittery, Dietitians Organizations: Florence Comite, Service, Business, Allied Market Research, Comite Center, Precision Medicine & Health, Nutrition Board, National Academies of Sciences Engineering, Medicine, Comite Locations: Florence, York
Intermittent fasting diet plans, meal kits, fitness trackers, and biological age tests can all offer something to busy people who want to feel in control. More than one in 10 Americans (12%) tried intermittent fasting in 2023, according to one food and beverage industry-backed survey. The business of intermittent fasting phone apps is blossoming and is on track for more growth in the next five to 10 years. There are many ways to do intermittent fasting — from skipping breakfast to whole days without foodPeople have been fasting for as long as people have been people. AdvertisementThe case against fasting to lose weight and live longerFirefighters in San Diego tried intermittent fasting out during the pandemic, with good results.
Persons: , Chris Hemsworth, Podcaster Andrew Huberman, Hugh Jackman, Dwayne, Johnson, Terry Crews, It's, Sam Altman, biohacking, Dave Asprey, Gary Vaynerchuk, Bryan Johnson, Jack Dorsey, it's, Hippocrates, Daniel Belsky, There's, Satchidananda Panda, I've, Krista Varady, Dr, Peter Attia, you've, Satchidananda, He's, Randy Shropshire, nix, Valter Longo, Longo, Belsky, Stephen Kritchevsky, Mark Cucuzzella, Nir Barzilai, Nir Barzilai Nir Barzilai, Barzilai, Panda, That's, Cucuzzella Organizations: Service, Business, Columbia University, 16ers, Salk Institute for Biological Studies, University of Illinois, Getty, Cancer, gerontology, USC, Firefighters, Wake Forest University, West Virginia University School of Medicine, Institute for Aging Research, Albert Einstein College of Medicine Locations: Greece, Chicago, San Diego, New York
Dr. Florence Comite is a precision medicine doctor whose focus is helping her patients live longer. AdvertisementA precision medicine doctor shared the five simple things she does to try to live longer with Business Insider. Comite does resistance training, such as lifting weights, twice a week. Comite told BI that within six months of taking astragalus, her eyesight improved and she no longer needs reading glasses. AdvertisementThe National Center for Complementary and Integrative Health warns that taking astragalus orally might have the following side effects: rash, itching, nasal symptoms, and stomach discomfort.
Persons: , Bryan Johnson, it's, Florence Comite, You've Organizations: Florence Comite, Service, Business, Comite Center, Precision Medicine & Health, World Health Organization, National Center, Integrative Health, Comite, Yale, Center Locations: Florence, York, Mount Sinai
Read previewA precision medicine doctor shared the six supplements she takes daily in the hope they will help her live longer. Tech exec and biohacker Bryan Johnson , for instance, takes over 100 pills a day to supplement his diet, including spermidine and lithium, while longevity doctor Peter Attia takes vitamin D and magnesium. AdvertisementHere’s what you need to know about six of the supplements she takes each day. So, some researchers think that maintaining DHEA levels could have an antiaging effect. However, evidence links low DHEA levels with these issues but doesn’t prove that it causes them.
Persons: , biohacker Bryan Johnson, Peter Attia, Florence Comite, American Heart Association doesn’t, they’ve, DHEA Organizations: Service, Business, Tech, Comite Center, Precision Medicine & Health, Cleveland Clinic, American Heart Association Locations: Florence, York, Mount Sinai, Comite
Read previewA precision medicine doctor, who tailors her patients’ care to boost their longevity, shared the recipe for the simple, four-ingredient protein smoothie that she drinks every morning. This story is available exclusively to Business Insider subscribers. 4-ingredient chocolate smoothie recipeBerriesDark chocolateWhey protein (at least 20 grams protein per scoop)IceAdvertisementComite simply blitzes these ingredients together in a food blender and then drinks it on the move. Comite thinks of dark chocolate as a supplementComite considers dark chocolate a supplement because it is so “rich in powerful flavonoids,” which are antioxidants that come from plants. Comite uses a brand called CocoaVia, but you can use any dark chocolate, she said.
Persons: , Florence Comite, Ludlam, Raine Organizations: Service, Precision Medicine & Health, Business, Comite Locations: Florence, York, Comite
How to fight dementia, according to neurologists
  + stars: | 2024-02-12 | by ( Sandee Lamotte | ) edition.cnn.com   time to read: +17 min
What about diabetes, cancer, thyroid disease, high blood pressure or heart disease? Some of the questions might seem unexpected to those who don’t write about brain health. However, my risk of developing vascular dementia, the second most common type after Alzheimer’s disease, is elevated. "Such spikes cause brain inflammation, disrupt brain metabolism and increase shrinkage of the thinking part of the brain," Isaacson said. The National Institute on Aging currently supports nearly 500 active clinical trials on Alzheimer’s disease and related dementias.
Persons: Louise Dittner, Krysta, Ryan LaMotte, It’s, , Natalia Rost, , Rost, ” Rost, Richard Isaacson, ” Isaacson, mockingbird …, birthed, it’s, I’ve, Isaacson, Sandee LaMotte Organizations: CNN, Comprehensive, Massachusetts General Hospital, Harvard Medical School, American Academy of Neurology, Boca Raton, Weill Cornell Medicine, Presbyterian, Mayo Clinic, Volunteers, Alzheimer’s, National Institute on Aging, National Institutes of Health Locations: Massachusetts, Boston, neonatologists, Florida, United, New York, New York City, Nature
Healthy aging is a buzzy topic right now, so you may be wondering how you can increase your longevity. But copying what your friends or multi-millionaire biohackers are doing isn't necessarily the best approach. But Dr. Florence Comite, an endocrinologist and founder of the New-York based Comite Center for Precision Medicine and Health , told Business Insider that it's possible to increase our chances of living longer by using the basic concepts of personalized medicine. This story is available exclusively to Business Insider subscribers. But in the meantime, Comite has tips for tweaking your health and fitness routines to improve your health span.
Persons: biohackers, Florence Comite, It's Organizations: Service, Comite Center, Precision Medicine, Health, Business, Comite Locations: Florence, York
Stock Chart Icon Stock chart icon U.S. Silica's year-to-date stock performance. Stock Chart Icon Stock chart icon Tetra Tech's year-to-date stock performance. Stock Chart Icon Stock chart icon RxSight's year-to-date stock performance. Stock Chart Icon Stock chart icon Praxis Precision Medicines' year-to-date stock performance. Stock Chart Icon Stock chart icon Getty's year-to-date stock performance.
Persons: they're Organizations: Tetra Tech, Medicines, Precision Medicines
Read previewWith the Ozempic craze in full swing, investors are getting picky about the weight-loss startups they want to back. Kaganoff predicted that in the new year some startups prescribing GLP-1s would invest more money in studies using real-world evidence to show their programs work. And despite the Ozempic frenzy, weight-loss startups captured a tiny fraction of the money invested this year. Investors had put about $211 million toward weight-loss startups through mid-November, representing about 3% of digital-health funding over that period, according to PitchBook. Alfie HealthSome unlikely sectors of the healthcare industry stand to benefit from the growth of the weight-loss market.
Persons: , Sari Kaganoff, Crystal Cox, Kaganoff, Ro, VCs, Michael Greeley, Alyssa Jaffee, 7wireVentures, she's, she'd, Mounjaro, Mercer, Michael Siluk, PitchBook, Alfie Health, it's, Alfie's cofounders, Aaron DeGagne, Jordan, he'd, DeGagne, There's Organizations: Service, Business, Rock Health, Flare Capital Partners, Getty, Employers, Health, Investors, Phenomix Sciences, Mayo Clinic, PitchBook, Tusk Venture Partners, Sword Health Locations: GLP
The Biden administration said on Monday that it had chosen 31 regions as potential recipients of federal money that would seek to fund innovation in parts of the country that government investment overlooked in the past. The announcement was the first phase of a program that aims to establish so-called tech hubs around the country across a variety of cutting-edge industries, like quantum computing, precision medicine and clean energy. In the coming months, the regions will compete for a share of $500 million, with roughly five to 10 of the projects receiving up to about $75 million each, the administration said. The program will test a central idea of a bipartisan bill that lawmakers passed last year: that science and technology funding should not just be concentrated in Silicon Valley and a few thriving coastal regions but flow to parts of the country that are less populated or have historically received less government funding. Proponents of the program say these investments can tap into pools of workers and economic resources that are not reaching their full potential, and improve the American economy as well as its technological abilities.
Persons: Biden Locations: Silicon Valley
Tsai predicts that AI will one day help doctors analyze complicated genetic data — a hallmark of precision medicine. Together, AI imaging and genetic analysis may help doctors rapidly pinpoint a diagnosis and create a highly personalized treatment plan, thus improving a patient's care. AI and the potential for genetic analysisIn addition to medical imaging, AI could one day comb through large amounts of genetic information, a challenging task for researchers. A possible convergence in the clinicWang does not see combining AI imaging and AI genetic analysis at the doctor's office happening within the next couple of years. Chang and his colleagues are investigating how AI analysis of brain scans can predict genetic mutations in brain tumors.
Persons: James C, Tsai, Peter D, Chang, Zhenghe J, Wang Organizations: Healthcare, Morning, Center, Ophthalmic Artificial Intelligence, Human, Icahn School of Medicine, US Food and Drug Administration, Applied, Research, University of California, Case Western Reserve University Locations: Mount, Irvine
Savoy Life is building a virtual care platform for long-term care facilities. Peter Emigh, Savoy Life's founder and CEO, said he saw the need to improve long-term care facilities while working as a healthcare administrator at CareMore Health. He said improving the lives of everyday residents receiving long-term care starts with giving operators of those communities more – and better – tools. Savoy Life is entering an already booming market focused on the aging population, which could grow to north of $2 trillion by 2028, according to research consultancy Markets N Research. Check out the nine-slide pitch deck that Savoy Life used to raise $3 million and launch out of stealth.
Persons: Peter Emigh, Savoy, Organizations: Red Cell Partners, American Healthcare Association, National Center for, CareMore, Research, Frontrunners
Morgan Stanley thinks little-known drug developer Evotec could benefit from artificial intelligence advancements in Europe and new collaborations with peer companies. EVO YTD mountain Evotec SE stock has surged 40% from the start of the year. Meanwhile, a security breach in April did little to caution Quigley away from the stock. The analyst highlighted the company's potential to better use AI to aid in drug development in the future, as well as partnerships with big pharma names. "A number of Pharma companies are investing in internal AI/ML efforts," he added.
Persons: Morgan Stanley, Morgan Stanley's, James Quigley, Quigley, Evotec, Eli Lilly, — CNBC's Michael Bloom Organizations: pharma, Merck & Co, Bristol Myers Squibb, Novo Nordisk Locations: Europe, Germany
“If you can understand the role, the protein structure and role, now you can start developing drugs around that,” Maniar said. Scientists can take around 12 months just to identify a biological target, according to the National Center for Biotechnology Information. Google Cloud’s suite has a three-pronged approach for making that process more efficient. The final component of Google Cloud’s suite helps researchers identify how the protein’s structure interacts with different molecules. But Renger said the company will be able to weed out molecules faster using Google Cloud's suite.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe're using A.I. to predict patient responses to specific cancer therapy: Medical A.I. companyBrandon Suh, CEO of Lunit, says because cancer is a complex disease that can't be tackled with a single drug, using personalized and precision medicine to treat it has been a recent trend.
Total: 25